Skip to content

RE-ACT: Developing and testing a psychological intervention to reduce psychological distress among patients with advanced cancer

Developing and testing an Acceptance and Commitment Therapy (ACT) telehealth intervention to reduce psychological distress among patients with advanced cancer - RE-ACT: Development and testing of an ACT telehealth intervention for psychological distress in patients who live longer with advanced cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57853
Enrollment
70
Registered
2025-03-12
Start date
2026-02-20
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced cancer, metastasized cancer advanced cancer

Interventions

The RE-ACT intervention is an online individual face-to-face psychological treatment adapted from an existing intervention and based on Acceptance and Commitment Therapy. The intervention consists of

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: = 18 years old;able to speak and read Dutch;diagnosed with metastatic cancer at least 6 months prior;non-curative treatment intentpoor or uncertain prognosis, life expectancy of = 12 months;receiving ongoing systemic cancer treatment for > 3 months (interruption of treatment of 3-6 months allowed);an Eastern Cooperative Oncology Group (ECOG) performance score of 0-2;moderate-severe psychological distress during the past two weeks (i.e., total score = 11 on the Hospital Anxiety and Depression Scale (HADS));having a psychological request for help

Exclusion criteria

Exclusion criteria: breast or prostate cancer with bone-only metastheses (i.e. without metastases elsewhere);severe psychiatric disorder that meets DSM-5 criteria (e.g. untreated trauma unrelated to cancer, high / imminent suicidality);concurrent psychological treatment (including antidepressants with the exception of antidepressants for uncontrolled pain) 

Design outcomes

Primary

MeasureTime frame
(1) demand, (2) acceptability, (3) integration, (4) preliminary efficacy

Secondary

MeasureTime frame
use of supportive care services, drop-out

Countries

Netherlands

Contacts

Public ContactH. Poort

Radboud Universitair Medisch Centrum

hanneke.poort@radboudumc.nl024 3616361

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 3, 2026